See this comprehensive information from ACT Health about the safe and appropriate use of blood and blood products.
Safe and Appropriate Use of Blood and Blood Products
Criteria for the Use of Intravenous Immunoglobulin (IVIG) in Australia
Criteria for the Use of Intravenous Immunoglobulin (IVIG) in Australia were released in March 2008 to assist clinicians and transfusion medicine professionals identify the conditions and circumstances for which the use of IVIg is appropriate. For information regarding this criterion follow the link
Haemovigilance
Blood products and transfusion practices are not risk free. ACT Health is working collaboratively with other jurisdictions to collect data and improve transfusion practice
ACT Health staff should report all transfusion reactions through Riskman and to the Transfusion CNC by emailing: Maria.burgess@act.gov.au
Publications
Blood transfusion fact sheet
| Download: | Blood transfusion fact sheet (November 2009) (PDF File - 156k) |
Blood transfusion brochure
| Download: | Blood transfusion (November 2009) (PDF File - 185k) |
Blood transfusion questions and answers
| Download: | Blood transfusion QA (November 2009) (PDF File - 114k) |
Inclusion of the Manufacturing Cost on Blood Bag Labels
| Download: | Title: Fact Sheet - Inclusion of the Manufacturing Cost on Blood Bag Labels (PDF File - 201k) |
Contact us
To obtain one of our blood transfusion publications, contact Maria Burgess at: maria.burgess@act.gov.au
Training and Education
For training and education on Transfusion Safety contact Maria Burgess by emailing: Maria.burgess@act.gov.au
Policies
- Blood and Blood Product Administration Policy
- Massive Transfusion Policy
- Patient Identification and Pathology Specimen Labelling
